CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Spain

8 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Universitario Donostia, Donostia · Hospital Clínico San Carlos, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-11-03
NCT06920004
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Trial Treatment · Phase 3 · argenx
Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-11-03
NCT06858579
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Clinical Study Site, Alicante · Clinical Study Site, Barcelona · Cinical Study Site, Barcelona · Clinical Study Site, Bilbao
Registry updated 2026-10-28
NCT06859099
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Trial Treatment · Phase 3 · Sanofi
Investigational Site Number : 7240002, Barcelona · Investigational Site Number :7240001, Barcelona · Investigational Site Number :7240004, Majadahonda · Investigational Site Number : 7240008, Málaga · Investigational Site Number :7240006, Pamplona · Investigational Site Number : 7240003, Valencia
Registry updated 2026-10-27
NCT06290141
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 3 · Sanofi
Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Regional de Málaga, Málaga · Hospital Universitario Central De Asturias, Oviedo · Hospital Universitario de Navarra, Pamplona · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-19
NCT07032662
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2 · Immunovant Sciences GmbH
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-09-30
2024-517529-26-00
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics Inc.
Hospital General Universitario Dr. Balmis, Alicante · Hospital Germans Trias i Pujol, Badalona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Clínico San Carlos, Madrid
Registry updated 2026-08-28
NCT06299748
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Research · argenx
Hospital Universitari Vall d'Hebron, Barcelona
Registry updated 2026-02-17

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error